Cargando…
Isolation and characterization of cidofovir resistant vaccinia viruses
BACKGROUND: The emergence of drug resistant viruses, together with the possibility of increased virulence, is an important concern in the development of new antiviral compounds. Cidofovir (CDV) is a phosphonate nucleotide that is approved for use against cytomegalovirus retinitis and for the emergen...
Autores principales: | Becker, Marie N, Obraztsova, Maria, Kern, Earl R, Quenelle, Debra C, Keith, Kathy A, Prichard, Mark N, Luo, Ming, Moyer, Richard W |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2397383/ https://www.ncbi.nlm.nih.gov/pubmed/18479513 http://dx.doi.org/10.1186/1743-422X-5-58 |
Ejemplares similares
-
Cutaneous infections of mice with vaccinia or cowpox viruses and efficacy of cidofovir
por: Quenelle, Debra C, et al.
Publicado: (2004) -
Vaccinia virus lacking the deoxyuridine triphosphatase gene (F2L) replicates well in vitro and in vivo, but is hypersensitive to the antiviral drug (N)-methanocarbathymidine
por: Prichard, Mark N, et al.
Publicado: (2008) -
Treatment of Vaccinia and Cowpox Virus Infections in Mice with CMX001 and ST-246
por: Quenelle, Debra C., et al.
Publicado: (2010) -
Human cytomegalovirus UL27 is not required for viral replication in human tissue implanted in SCID mice
por: Prichard, Mark N, et al.
Publicado: (2006) -
Cidofovir for the Treatment of Molluscum Contagiosum Virus
por: De Clercq, Erik
Publicado: (2022)